Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Hoff

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|December 21, 2000
Novel oral chemotherapy agentsM E Royce, P M Hoff, R Pazdur
Japanese Journal of Clinical Oncology|June 2, 2001
Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1S A Elasmar, E D Saad, P M Hoff
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literatureE D Saad, A Katz, P M Hoff, et al.
Anti-Cancer Drugs|January 7, 1999
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancerP M Hoff, R Pazdur, S E Benner, et al.
Seminars in Oncology|December 22, 1999
Oral fluoropoyrimidinesP M Hoff, M Royce, D Medgyesy, et al.
Oncology (Williston Park, N.Y.)|November 27, 1998
The oral fluorouracil prodrugsR Pazdur, P M Hoff, D Medgyesy, et al.
Cancer|March 5, 1998
Hand-foot syndrome following prolonged infusion of high doses of vinorelbineP M Hoff, V Valero, N Ibrahim, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancerP M Hoff, E D Saad, N Janjan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Non-inferiority cancer clinical trials: scope and purposes underlying their designR P Riechelmann, A Alex, L Cruz, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Preoperative UFT and calcium folinate and radiotherapy in rectal cancerP M Hoff, Y Lassere, R Pazdur, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|December 21, 2000
Novel oral chemotherapy agentsM E Royce, P M Hoff, R Pazdur
Japanese Journal of Clinical Oncology|June 2, 2001
Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1S A Elasmar, E D Saad, P M Hoff
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literatureE D Saad, A Katz, P M Hoff, et al.
Anti-Cancer Drugs|January 7, 1999
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancerP M Hoff, R Pazdur, S E Benner, et al.
Seminars in Oncology|December 22, 1999
Oral fluoropoyrimidinesP M Hoff, M Royce, D Medgyesy, et al.
Oncology (Williston Park, N.Y.)|November 27, 1998
The oral fluorouracil prodrugsR Pazdur, P M Hoff, D Medgyesy, et al.
Cancer|March 5, 1998
Hand-foot syndrome following prolonged infusion of high doses of vinorelbineP M Hoff, V Valero, N Ibrahim, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancerP M Hoff, E D Saad, N Janjan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Non-inferiority cancer clinical trials: scope and purposes underlying their designR P Riechelmann, A Alex, L Cruz, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Preoperative UFT and calcium folinate and radiotherapy in rectal cancerP M Hoff, Y Lassere, R Pazdur, et al.
Pageof 5